![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
The 5 Year Safety and Efficacy of the Once-Daily Antiretroviral-Naïve Patient Regimen of Efavirenz (EFV)/Emtricitabine (FTC)/Tenofovir DF (TDF)
|
|
|
Reported by Jules Levin
Glasgow 2010 Nov 7-11
A Lazzarin,1 M Johnson,2 E Ribera,3 L Weitner,4 SS Chen,5 and DR Warren5 on behalf of the Study 934 Investigators
1Milano, Italy; 2London, United Kingdom; 3Barcelona, Spain;
4Hamburg, Germany; 5Gilead Sciences, Inc., Foster City, United States
![](../images/111810/111810-6/Conclusions-1.gif)
![](../images/111810/111810-6/background2.gif)
![](../images/111810/111810-6/design3.gif)
![](../images/111810/111810-6/results4.gif)
![](../images/111810/111810-6/cells5.gif)
![](../images/111810/111810-6/visti6.gif)
![](../images/111810/111810-6/pill7.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|